A recent cohort study (TRIBE–AKI Consortium) in adults used urinary biomarkers (tubular injury markers [NGAL, IL-18, KIM-1, L-FABP], tubular function markers [FeNa] and glomerular injury markers [albumin]) to differentiate between various causes of AKI in liver failure. Here, IL18 is linked to liver failure.